Maybe our perspective/expectations should be that
Post# of 147875
(Total Views: 496)
Posted On: 01/10/2021 2:31:14 AM
Maybe our perspective/expectations should be that the evaluation of data will end on Jan 12th, eg documention of symptoms and deaths, although recorded on Jan 13th, data on the 13th will not be included as part of our Phase III s/c trial?
And unblinding will be expected within days of Jan 12th?
This just goes on forever and ever. I can clearly hear Nader, anytime I want to hear it again in my mind: "Low Risk, High Return".
And unblinding will be expected within days of Jan 12th?
This just goes on forever and ever. I can clearly hear Nader, anytime I want to hear it again in my mind: "Low Risk, High Return".
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼